S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
NVAX · Novavax, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$11.01
-0.41
(-3.63%)
● At close: October 21 at 4:00:00 PM EDT
$10.91
-0.10
(-0.91%)
Overnight:
10:47:40 PM EDT
DAY'S RANGE
$11.01
$10.98
$11.46
52-WEEK RANGE
$11.01
$6.20
$13.38
What's happening
- NVAX is down 3.63% today, trading at $11.01. — Live quote
- Volume today (290,091) is well below its 3-month average of 5,417,520. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.32 actual vs. $-0.39 estimated (+18.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 6
Hold 2
Sell 2
Strong sell 1
Aggregate ratings for 2026-10-01 (15 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
NVAX
+70.09%
vs S&P 500
+57.31%
1-YEAR RETURN
NVAX
+30.03%
vs S&P 500
+15.47%
6-MONTH RETURN
NVAX
+32.29%
3-MONTH RETURN
NVAX
+41.55%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.32
Est. $-0.39
BEAT +18.6%
2026-04-26 (Q1 2026)
$-0.06
Est. $-0.23
BEAT +74.5%
2026-01-26 (Q4 2025)
$0.11
Est. $-0.50
BEAT +122.1%
2025-10-26 (Q3 2025)
$-1.25
Est. $-1.21
MISS -3.3%
Valuation Measures & Ratios
Enterprise Value4$1.96B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)4.48
Price / Book727.12
EV4 / Revenue4.73
EV4 / EBITDA4.34
Profit Margin-59.87%
Operating Margin-63.52%
Return on Equity (ROE8)283.08%
Return on Assets (ROA9)-22.75%
Avg Volume (3M)5,417,520
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.57B | $1.29B | $1.40B | $1.08B | $1.13B |
| P/E | -9.89 | 3.12 | 4.65 | 1.62 | 2.75 |
| Price/Sales | 3.10 | 1.16 | 1.32 | 0.77 | 0.90 |
| Price/Book | -8.24 | -8.91 | -8.95 | 28.76 | -15.00 |
| EV/Revenue | 3.30 | 1.21 | 1.07 | 0.59 | 0.69 |
| ROE | 83.24% | -285.49% | -192.42% | 1770.72% | -544.90% |
| ROA | -16.61% | 39.62% | 25.55% | 49.85% | 31.88% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short46,046,946
Change from Prior Settlement-7.68%
% of Float—
Days to Cover (Short Ratio)8.06
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +30.0%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-08-06; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -76.3% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -59.9%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on NVAX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $56.7M | $139.5M | $70.4M | $239.2M | $666.7M | $84.5M | $415.5M | $93.9M |
| Operating income | -$54.9M | -$15.4M | -$178.0M | $101.1M | $515.5M | -$134.0M | $161.0M | -$144.8M |
| Net income | -$53.4M | -$9.5M | -$202.4M | $106.5M | $518.6M | -$121.3M | $162.4M | -$147.6M |
| EPS (diluted) | $-0.32 | $-0.06 | $-1.25 | $0.62 | $2.93 | $-0.76 | $0.99 | $-1.05 |
| EPS (basic) | $-0.32 | $-0.06 | $-1.25 | $0.66 | $3.22 | $-0.76 | $1.09 | $-1.05 |
| Operating margin | -$97 | -$11 | -$253 | $42 | $77 | -$159 | $39 | -$154 |
| Net margin | -$94 | -$7 | -$287 | $45 | $78 | -$144 | $39 | -$157 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $955.6M | $1.04B | $1.18B | $1.18B | $1.34B | $1.29B | $1.56B | $1.71B |
| Total liabilities | $1.15B | $1.19B | $1.30B | $1.34B | $1.30B | $1.37B | $2.18B | $2.24B |
| Stockholders' equity | -$190.7M | -$144.8M | -$127.8M | -$156.7M | $37.6M | -$75.6M | -$623.8M | -$526.4M |
| Total current assets | $771.1M | $850.8M | $978.3M | $974.6M | $919.5M | $868.0M | $1.13B | $1.10B |
| Total current liabilities | $330.6M | $342.5M | $459.9M | $429.9M | $389.1M | $422.2M | $1.15B | $1.18B |
| Cash & equivalents | $191.5M | $228.4M | $240.6M | $268.0M | $253.7M | $263.3M | $530.2M | $573.6M |
| Marketable securities (current) | $527.9M | $562.0M | $494.4M | $494.9M | $358.6M | $468.1M | $392.9M | $335.9M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | $10.0M | $11.5M | $11.5M | $13.5M | $10.2M | $10.3M | $8.7M | $8.6M |
| Other current assets | — | — | $9.9M | — | — | — | $21.9M | — |
| Property, plant & equipment | $38.1M | $42.1M | $44.8M | $49.1M | $129.6M | $133.5M | $138.4M | $285.7M |
| Goodwill | $112.5M | $112.9M | $113.5M | $113.1M | $113.0M | $112.0M | $107.5M | $126.8M |
| Intangible assets | — | — | — | — | — | — | — | — |
| Other non-current assets | $14.0M | $16.0M | $17.1M | $19.2M | $21.4M | $21.9M | $24.0M | $30.5M |
| Accounts payable | $22.9M | $16.1M | $24.6M | $15.2M | $50.6M | $34.2M | $41.6M | $57.5M |
| Accrued liabilities | $81.4M | $103.0M | $107.2M | $115.6M | $86.7M | $132.2M | $211.2M | $218.7M |
| Deferred revenue (current) | $86.6M | $88.8M | $140.1M | $104.3M | $113.8M | $108.3M | $675.1M | $613.4M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $135.5M | $132.4M | $137.8M | $138.3M | $132.5M | $142.0M | $219.6M | $281.7M |
| Long-term debt | $291.5M | $291.0M | $244.2M | — | — | — | — | — |
| Other non-current liabilities | $165.7M | $193.2M | $239.1M | $263.5M | $287.6M | $313.7M | $359.6M | $318.9M |
| Common stock & paid-in capital | $1.7M | $1.7M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M |
| Retained earnings | -$4.63B | -$4.58B | -$4.57B | -$4.59B | -$4.38B | -$4.49B | -$5.01B | -$4.93B |
| Accumulated other comprehensive income (loss) | -$7.4M | -$5.1M | $2.0M | -$1.7M | -$458.0K | $1.6M | -$22.6M | $3.6M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$72.8M | -$32.4M | -$39.5M | $107.8M | -$127.5M | -$185.5M | -$173.2M | -$144.8M |
| Investing cash flow | $34.9M | -$28.4M | $20.5M | -$136.5M | $111.1M | -$73.3M | $144.0M | $31.9M |
| Financing cash flow | $1.2M | $37.7M | -$6.6M | $42.4M | -$1.0M | -$7.1M | -$3.4M | -$97.0K |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | — | — | $28.0M | — | — | — | $48.0M | — |
| Share-based compensation | $8.1M | $7.7M | $8.0M | $8.5M | $9.2M | $10.3M | $10.4M | $12.0M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in inventory | $318.0K | $226.0K | -$2.1M | $3.8M | $4.0M | -$2.4M | $189.0K | $1.1M |
| Purchases of investments | $81.7M | $214.1M | — | $235.0M | $0 | $114.7M | — | $71.7M |
| Sales/maturities of investments | $117.2M | $147.3M | $98.6M | $100.5M | $111.6M | $43.0M | $337.9M | $105.6M |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $1.12B | $682.2M | $983.7M | $1.98B | $1.15B |
| Operating income | $452.8M | -$248.9M | -$566.5M | -$644.7M | -$1.69B |
| Net income | $440.3M | -$187.5M | -$545.1M | -$657.9M | -$1.74B |
| EPS (diluted) | $2.58 | $-1.23 | $-5.41 | $-8.42 | $-23.44 |
| EPS (basic) | $2.72 | $-1.23 | $-5.41 | $-8.42 | $-23.44 |
| Operating margin | $40 | -$36 | -$58 | -$33 | -$147 |
| Net margin | $39 | -$27 | -$55 | -$33 | -$152 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.18B | $1.56B | $1.80B | $2.26B | $2.58B |
| Total liabilities | $1.30B | $2.18B | $2.51B | $2.89B | $2.93B |
| Stockholders' equity | -$127.8M | -$623.8M | -$716.9M | -$634.1M | -$351.7M |
| Total current assets | $978.3M | $1.13B | $1.14B | $1.70B | $2.16B |
| Total current liabilities | $459.9M | $1.15B | $1.64B | $2.46B | $2.39B |
| Cash & equivalents | $240.6M | $530.2M | $568.5M | $1.34B | $1.52B |
| Marketable securities (current) | $494.4M | $392.9M | $0 | — | $0 |
| Accounts receivable | — | — | — | — | $455.0M |
| Inventory | $11.5M | $8.7M | $41.7M | $36.7M | $8.9M |
| Other current assets | $9.9M | $21.9M | $155.7M | $76.4M | $44.6M |
| Property, plant & equipment | $44.8M | $138.4M | $305.8M | $294.2M | $225.7M |
| Goodwill | $113.5M | $107.5M | $127.5M | $126.3M | $131.5M |
| Intangible assets | — | — | — | — | $4.8M |
| Other non-current assets | $17.1M | $24.0M | $35.2M | $28.5M | $24.3M |
| Accounts payable | $24.6M | $41.6M | $132.6M | $216.5M | $127.0M |
| Accrued liabilities | $107.2M | $211.2M | $394.7M | $591.2M | $673.7M |
| Deferred revenue (current) | $140.1M | $675.1M | $241.3M | $370.1M | $1.40B |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $137.8M | $219.6M | $861.4M | $930.1M | $36.1M |
| Other non-current liabilities | $239.1M | $359.6M | $33.1M | $55.7M | $42.1M |
| Common stock & paid-in capital | $1.6M | $1.6M | $1.4M | $868.0K | $764.0K |
| Retained earnings | -$4.57B | -$5.01B | -$4.82B | -$4.28B | -$3.62B |
| Accumulated other comprehensive income (loss) | $2.0M | -$22.6M | $2.7M | -$6.4M | -$1.4M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$244.6M | -$87.3M | -$714.0M | -$415.9M | $322.9M |
| Investing cash flow | -$78.3M | -$204.0M | -$58.8M | -$93.0M | $100.2M |
| Financing cash flow | $27.7M | $260.6M | $4.5M | $325.0M | $461.7M |
| Depreciation & amortization | $28.0M | $48.0M | $41.0M | $29.0M | $13.0M |
| Share-based compensation | $36.0M | $48.2M | $85.4M | $130.3M | $183.6M |
| Deferred income taxes | — | — | — | — | — |
| Change in accounts receivable | — | — | — | — | — |
| Change in inventory | $3.2M | -$12.9M | $74.5M | $477.8M | $8.9M |
| Sales/maturities of investments | $353.7M | $443.6M | $0 | $0 | — |
| Tax withholding on stock comp | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding NVAX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers63.8%
Shares Outstanding164,815,529
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| SHAH CAPITAL MANAGEMENT | 14,165,577 | $133.4M | 8.59% | -4.6% | 2026-08-14 |
| BlackRock, Inc. | 13,946,881 | $131.4M | 8.46% | +8.6% | 2026-08-07 |
| State Street Corp | 11,740,550 | $110.6M | 7.12% | +30.9% | 2026-08-07 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,607,996 | $71.7M | 4.62% | +6.4% | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,257,449 | $68.4M | 4.40% | +1.8% | 2026-06-30 |
| Sanofi | 6,880,481 | $64.8M | 4.17% | +0.0% | 2026-07-28 |
| D. E. Shaw & Co., Inc. | 5,650,905 | $53.2M | 3.43% | -26.7% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,207,370 | $39.6M | 2.55% | +7.9% | 2026-08-12 |
| TWO SIGMA INVESTMENTS, LP | 4,091,043 | $38.5M | 2.48% | +565.4% | 2026-08-07 |
| COATUE MANAGEMENT LLC | 3,836,986 | $36.1M | 2.33% | +0.0% | 2026-08-14 |
| Bank Of America Corp /De/ | 3,416,235 | $32.2M | 2.07% | -48.5% | 2026-08-14 |
| Goldman Sachs Group Inc | 3,007,756 | $28.3M | 1.82% | +113.4% | 2026-08-14 |
| UBS Group AG | 1,869,659 | $17.6M | 1.13% | -58.2% | 2026-08-13 |
| MILLENNIUM MANAGEMENT LLC | 1,768,163 | $16.7M | 1.07% | -54.1% | 2026-08-14 |
| CITADEL ADVISORS LLC | 1,695,313 | $16.0M | 1.03% | +50.9% | 2026-08-14 |
| Allianz Asset Management GmbH | 1,579,200 | $14.9M | 0.96% | -15.1% | 2026-08-11 |
| Northern Trust Corp | 1,448,108 | $13.6M | 0.88% | -4.1% | 2026-08-12 |
| TSP Capital Management Group, LLC | 1,419,365 | $13.4M | 0.86% | +2.1% | 2026-07-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,346,607 | $12.7M | 0.82% | -2.0% | 2026-08-14 |
| VANGUARD FIDUCIARY TRUST CO | 1,085,100 | $10.2M | 0.66% | -2.0% | 2026-06-30 |
| JUPITER ASSET MANAGEMENT LTD | 1,070,232 | $10.1M | 0.65% | +0.0% | 2026-08-10 |
| AQR CAPITAL MANAGEMENT LLC | 902,650 | $8.5M | 0.55% | +705.5% | 2026-08-14 |
| Bank of New York Mellon Corp | 849,718 | $8.0M | 0.52% | +8.8% | 2026-08-06 |
| Federated Hermes, Inc. | 703,006 | $6.6M | 0.43% | +14690.8% | 2026-08-12 |
| Point72 Asset Management, L.P. | 664,286 | $6.3M | 0.40% | -56.2% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-10-29 to 2026-06-20
Recent transactions
- Most recent: Rodgers Richard J (Director) — Option exercise of 18,880 shares on 2026-06-20.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Rodgers Richard J | Director | Option exercise | 2026-06-20 | 18,880 |
| King Rachel K. | Director | Option exercise | 2026-06-20 | 18,880 |
| DOUGLAS RICHARD | Director | Option exercise | 2026-06-20 | 18,880 |
| MCGLYNN MARGARET G | Director | Option exercise | 2026-06-20 | 18,880 |
| MOTT DAVID M | Director | Option exercise | 2026-06-20 | 18,880 |
| Alton Gregg H | Director | Option exercise | 2026-06-20 | 18,880 |
| Newton Charles W. | Director | Option exercise | 2026-04-25 | 9,520 |
| Shiver John W. | Director | Option exercise | 2026-03-10 | 7,947 |
| Kelly James Patrick | EVP, CFO and Treasurer | Option exercise | 2026-03-07 | 12,223 |
| Jacobs John C | President and CEO | Option exercise | 2026-03-03 | 150,167 |
| O'Hara Elaine | EVP, Chief Strategy Officer | Option exercise | 2026-03-03 | 56,334 |
| Casey Mark J | EVP, Chief Legal Officer | Option exercise | 2026-03-03 | 37,500 |
| Draghia-Akli Ruxandra | EVP, Research & Development | Option exercise | 2026-03-03 | 26,667 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-20 | Rodgers Richard J | Director | Option exercise | 18,880 | — |
| 2026-06-20 | King Rachel K. | Director | Option exercise | 18,880 | — |
| 2026-06-20 | DOUGLAS RICHARD | Director | Option exercise | 18,880 | — |
| 2026-06-20 | MCGLYNN MARGARET G | Director | Option exercise | 18,880 | — |
| 2026-06-20 | MOTT DAVID M | Director | Option exercise | 18,880 | — |
| 2026-06-20 | Alton Gregg H | Director | Option exercise | 18,880 | — |
| 2026-04-25 | Newton Charles W. | Director | Option exercise | 9,520 | $0.00 |
| 2026-03-10 | Shiver John W. | Director | Option exercise | 7,947 | $0.00 |
| 2026-03-07 | Kelly James Patrick | EVP, CFO and Treasurer | Option exercise | 12,223 | $0.00 |
| 2026-03-07 | Kelly James Patrick | EVP, CFO and Treasurer | Tax withholding | 5,904 | $9.98 |
| 2026-03-03 | Kelly James Patrick | EVP, CFO and Treasurer | Option exercise | 43,167 | $0.00 |
| 2026-03-03 | Kelly James Patrick | EVP, CFO and Treasurer | Tax withholding | 20,850 | $9.49 |
| 2026-03-03 | Jacobs John C | President and CEO | Option exercise | 150,167 | $0.00 |
| 2026-03-03 | Jacobs John C | President and CEO | Tax withholding | 69,288 | $9.49 |
| 2026-03-03 | O'Hara Elaine | EVP, Chief Strategy Officer | Option exercise | 56,334 | $0.00 |
| 2026-03-03 | O'Hara Elaine | EVP, Chief Strategy Officer | Tax withholding | 22,429 | $9.49 |
| 2026-03-03 | Casey Mark J | EVP, Chief Legal Officer | Option exercise | 37,500 | $0.00 |
| 2026-03-03 | Casey Mark J | EVP, Chief Legal Officer | Tax withholding | 11,378 | $9.49 |
| 2026-03-03 | Draghia-Akli Ruxandra | EVP, Research & Development | Option exercise | 26,667 | $0.00 |
| 2026-03-03 | Draghia-Akli Ruxandra | EVP, Research & Development | Tax withholding | 11,313 | $9.49 |
| 2026-03-01 | Jacobs John C | President and CEO | Option exercise | 83,333 | $0.00 |
| 2026-03-01 | Jacobs John C | President and CEO | Tax withholding | 38,450 | $10.14 |
| 2026-03-01 | Kelly James Patrick | EVP, CFO and Treasurer | Option exercise | 58,666 | $0.00 |
| 2026-03-01 | Kelly James Patrick | EVP, CFO and Treasurer | Tax withholding | 28,366 | $10.14 |
| 2026-03-01 | O'Hara Elaine | EVP, Chief Strategy Officer | Option exercise | 19,600 | $0.00 |
| 2026-03-01 | O'Hara Elaine | EVP, Chief Strategy Officer | Tax withholding | 5,375 | $10.14 |
| 2026-03-01 | O'Hara Elaine | EVP, Chief Strategy Officer | Option exercise | 40,000 | $0.00 |
| 2026-03-01 | O'Hara Elaine | EVP, Chief Strategy Officer | Tax withholding | 10,969 | $10.14 |
| 2026-03-01 | Casey Mark J | EVP, Chief Legal Officer | Option exercise | 4,000 | $0.00 |
| 2026-03-01 | Casey Mark J | EVP, Chief Legal Officer | Tax withholding | 1,214 | $10.14 |
| 2026-01-23 | Jacobs John C | President and CEO | Option exercise | 83,197 | $0.00 |
| 2026-01-23 | Jacobs John C | President and CEO | Tax withholding | 39,132 | $9.17 |
| 2025-12-11 | Casey Mark J | EVP, Chief Legal Officer | Option exercise | 41,899 | $0.00 |
| 2025-12-11 | Casey Mark J | EVP, Chief Legal Officer | Tax withholding | 12,713 | $6.69 |
| 2025-11-11 | Draghia-Akli Ruxandra | Section 16 | Option exercise | 14,257 | $0.00 |
| 2025-11-11 | Draghia-Akli Ruxandra | Section 16 | Tax withholding | 6,048 | $7.40 |
| 2025-10-29 | Rodgers Richard J | Director | Option exercise | 3,800 | — |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:59 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-23 | 8-K | 2026-06-18 | View on SEC.gov → |
| 2026-05-06 | 8-K | 2026-05-06 | View on SEC.gov → |
Recent news
Headlines about NVAX (Novavax, Inc.). Links open the publisher — we don’t host full articles.
-
Novavax, Inc. (NVAX) Latest Stock News & Headlines
Yahoo Finance · 2026-10-21 -
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Yahoo · 2026-10-21 -
Novavax, Inc. (NVAX) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Novavax, Inc. (NVAX) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
Yahoo · 2026-10-20 -
Novavax (NVAX) Stock Declines While Market Improves: Some Information for Investors
Yahoo · 2026-10-19 -
Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push
Benzinga · 2026-10-19 -
Novavax stock fell 12.17 percent on October 16, 2026, 15.91 percent below its 52-week high - ad-hoc-news.de
ad-hoc-news.de · 2026-10-17
No headlines in this category right now — try “All”.